The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models

The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models

Online Mendelian Inheritance in Man (OMIM) is a complete, authoritative and well timed knowledgebase of human genes and genetic issues compiled to assist human genetics analysis and training and the follow of medical genetics. Started by Dr Victor A. McKusick because the definitive reference Mendelian Inheritance in Man, OMIM (http://www.ncbi.nlm.nih.gov/omim/) is now distributed electronically by the National Center for Biotechnology Information, the place it’s built-in with the Entrez suite of databases.

Derived from the biomedical literature, OMIM is written and edited at Johns Hopkins University with enter from scientists and physicians all over the world.

FDG-PET/CT in lymphoma

Each OMIM entry has a full-text abstract of a genetically decided phenotype and/or gene and has quite a few hyperlinks to different genetic databases corresponding to DNA and protein sequence, PubMed references, normal and locus-specific mutation databases, HUGO nomenclature, MapViewer, GeneTests, affected person assist teams and many others. OMIM is a simple and simple portal to the burgeoning info in human genetics.

The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models
The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models

Lymphomas are a heterogeneous group of illnesses that come up from the constituent cells of the immune system or from their precursors. 18F-fludeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) is now the cornerstone of staging procedures within the state-of-the-art administration of Hodgkin’s illness and aggressive non-Hodgkin’s lymphoma.

It performs an essential function in staging, restaging, prognostication, planning applicable remedy methods, monitoring remedy, and detecting recurrence. However, its function in indolent lymphomas continues to be unclear and calls for additional investigational trials.

The protean PET/CT manifestations of lymphoma necessitate a familiarity with the spectrum of imaging findings to allow correct analysis. A meticulous analysis of PET/CT findings, an understanding of its function within the administration of lymphomas, and data of its limitations are obligatory for the optimum utilization of this system.